Cargando…
Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines
BACKGROUND AND RESEARCH QUESTION: Loss of exclusivity of oncology drugs causes an important drop in their price due to the marketing of generic medicines. In this article we study how the price of certain oncology drugs evolves throughout time after the loss of their patent, both in terms of the not...
Autores principales: | Martínez-Sesmero, José M., Smith, Borja, Madurga, Julen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AboutScience
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768611/ https://www.ncbi.nlm.nih.gov/pubmed/36628314 http://dx.doi.org/10.33393/grhta.2022.2366 |
Ejemplares similares
-
Time to Marketing of Generic Drugs After Patent Expiration in Canada
por: Lexchin, Joel
Publicado: (2021) -
An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023) -
The impact of patent expiry on drug prices: insights from the Dutch market
por: van der Schans, Simon, et al.
Publicado: (2020) -
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017) -
Marketing before patenting: implications for price controls in Canada
por: Lexchin, Joel
Publicado: (2010)